ABCA1 and Alzheimer disease: Further, unlike ABCA1, it is reported that ABCA2 downregulation by siRNA decreases Aβ production.33The literature findings suggest downregulating ABCA2 to reduce Aβ production as a therapeutic approach to AD therapy.